/

Other

/

Amarin Corporation

Amarin Corporation

Amarin Corporation

Verified Nov 2026

Other

·

United States flag

Bridgewater, New Jersey

·

Since 1991

Amarin Corporation is a biopharmaceutical company headquartered in Bridgewater, New Jersey, founded in 1991, with 50–100 employees and estimated revenue of $100–250 million. It develops cardiovascular therapeutics for global markets, particularly in the United States and Europe. The company's primary product, Vascepa (icosapent ethyl), is an FDA-approved high-purity omega-3 prescription medication used to reduce cardiovascular risk in high-risk patients with elevated triglycerides.

Amarin Corporation

Verified Nov 2026

AT A GLANCE

Founded

1991

Headquarters

United States flag

Bridgewater, New Jersey

Employees

50-100

Ownership

Amarin Corporation at a glance

Revenue

$100-250M

Est. band

Employees

50-100

Founded

1991

Headquarters

Bridgewater, New Jersey

Industries

Automotive

Electric Vehicles

Medical

Industrial Equipment

Overview

Amarin Corporation is a biopharmaceutical company headquartered in Bridgewater, New Jersey, founded in 1991, with 50–100 employees and estimated revenue of $100–250 million. It develops cardiovascular therapeutics for global markets, particularly in the United States and Europe. The company's primary product, Vascepa (icosapent ethyl), is an FDA-approved high-purity omega-3 prescription medication used to reduce cardiovascular risk in high-risk patients with elevated triglycerides.

At a glance

Attribute

Detail

Founded

1991

Headquarters

Bridgewater, New Jersey

Employees

50-100

Revenue

$100-250M (estimated)

What Amarin Corporation makes

Amarin manufactures Vascepa as a prescription omega-3 therapeutic approved by the U.S. FDA and European EMA for use as an adjunct to statin therapy and for severe hypertriglyceridemia treatment.

Products and capabilities described on the company's own site include LED, Emissions (source: amarincorp.com).

Latest developments

Company details

The company operates with dual headquarters in Bridgewater, New Jersey, and Dublin, Ireland, and distributes its cardiovascular products through wholesalers and specialty pharmacies across multiple geographies. Amarin Corporation was founded in 1991, has an estimated 50-100 employees, and is headquartered in Bridgewater, New Jersey.

Frequently asked questions

What does Amarin Corporation do?

Amarin Corporation is a biopharmaceutical company headquartered in Bridgewater, New Jersey, founded in 1991, with 50–100 employees and estimated revenue of $100–250 million. It develops cardiovascular therapeutics for global markets, particularly in the United States and Europe. The company's primary product, Vascepa (icosapent ethyl), is an FDA-approved high-purity omega-3 prescription medication used to reduce cardiovascular risk in high-risk patients with elevated triglycerides.

Where is Amarin Corporation headquartered?

Amarin Corporation is headquartered in Bridgewater, New Jersey (440 U.S. 22, Bridgewater, New Jersey, 08807).

When was Amarin Corporation founded?

Amarin Corporation was founded in 1991.

How big is Amarin Corporation?

Amarin Corporation has an estimated 50-100 employees, with revenue in the $100-250M range (estimated).

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Bridgewater, New Jersey (HQ)Headquarters · United States
Bridgewater, New Jersey (HQ)440 U.S. 22, Bridgewater, New Jersey, 08807, United StatesHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.